Apple
A company. It sponsored the Apple Heart Study, and it is the applicant named in the US De Novo decision for the Irregular Rhythm Notification Feature.
Also called Apple Inc.
- Organization
- In this atlas
Overview
Technical summary
ClinicalTrials.gov NCT03335800 lists Apple Inc. as lead sponsor, with sponsor class INDUSTRY. The abstract of the main paper says the study was funded by Apple, and the openFDA De Novo record DEN180042 names Apple, Inc. as applicant. The regulator's database page calls it the requester. ROR record 059hsda18 lists Apple (United States) as a company and funder.
Roles
- Company
Sector
Industry
Record details
- Record id
cardio:apple- Content hash
e5054d9690e6939c298957b97d6d24aed227027e8757962adf61488271afd256